75 related articles for article (PubMed ID: 17913652)
21. Adjuvant chemotherapy for colorectal cancer.
Maughan TS
Br J Cancer; 2001 Nov; 85(10):1422-4. PubMed ID: 11720422
[No Abstract] [Full Text] [Related]
22. Targeted therapy in colorectal carcinoma: more than a theory.
Pickering L; Rudman S; Ross PJ; Leslie MD
Colorectal Dis; 2008 Mar; 10(3):209-18; discussion 218-221. PubMed ID: 18257846
[TBL] [Abstract][Full Text] [Related]
23. Chemoradiation an effective but toxic therapy for colorectal cancer.
Oncology (Williston Park); 1999 Sep; 13(9):1220. PubMed ID: 10509319
[No Abstract] [Full Text] [Related]
24. [Recent advances is surgical adjuvant chemotherapy for colorectal cancer].
Kodaira S; Shatari T; Nozawa K
Gan To Kagaku Ryoho; 2000 Dec; 27(14):2201-8. PubMed ID: 11142163
[TBL] [Abstract][Full Text] [Related]
25. Multiagent regimens for metastatic colorectal cancer: if some is good, more must be better.
Allegra C; George T; Yothers G
J Natl Cancer Inst; 2011 Jan; 103(1):4-5. PubMed ID: 21123834
[No Abstract] [Full Text] [Related]
26. Are we cautious enough when we interpret results of randomized but underpowered comparisons?
Paesmans M; Bleiberg H
J Clin Oncol; 2006 Apr; 24(12):1964-5. PubMed ID: 16622279
[No Abstract] [Full Text] [Related]
27. Integrating oxaliplatin and capecitabine in adjuvant therapy of high-risk colorectal cancer.
Maung K
Clin Colorectal Cancer; 2003 Nov; 3(3):150-3. PubMed ID: 14706173
[No Abstract] [Full Text] [Related]
28. [Progress of adjuvant chemotherapy in colon cancer].
Toge T
Gan To Kagaku Ryoho; 1996 Apr; 23(5):554-9. PubMed ID: 8678512
[TBL] [Abstract][Full Text] [Related]
29. [Does an effective adjuvant treatment in colorectal cancer exist?].
Díaz-Rubio E
Rev Clin Esp; 1993 Feb; 192(2):59-61. PubMed ID: 8460235
[No Abstract] [Full Text] [Related]
30. [Review of comparative studies of postoperative adjuvant chemotherapy after curatively resected colorectal cancer in Japan].
Mori T
Gan To Kagaku Ryoho; 2002 Sep; 29(9):1532-9. PubMed ID: 12355939
[TBL] [Abstract][Full Text] [Related]
31. Second-line option for colorectal cancer.
Cancer Discov; 2015 Mar; 5(3):OF3. PubMed ID: 25616856
[No Abstract] [Full Text] [Related]
32. Highlights in metastatic colorectal cancer from the 2012 American Society Of Clinical Oncology Annual Meeting.
Grothey A
Clin Adv Hematol Oncol; 2012 Jul; 10(7 Suppl 9):1-24. PubMed ID: 22895157
[No Abstract] [Full Text] [Related]
33. Repetita iuvant--INTACC (Intergruppo Italiano Terapia Adiuvante Carcinoma Del Colon).
Di Costanzo D; Gasperoni S; Dogliotti AL; Frassinetti L; Bruzzi P; Rosso R
Ann Oncol; 2001 Sep; 12(9):1331. PubMed ID: 11697849
[No Abstract] [Full Text] [Related]
34. Highlights from: XII European Cancer Conference, Copenhagen, Denmark, September 21-25, 2003.
Lee D; Price N; Tyagi P
Clin Colorectal Cancer; 2003 Nov; 3(3):142-6. PubMed ID: 14706171
[No Abstract] [Full Text] [Related]
35. Gastrointestinal cancer: Rationale for metronomic chemotherapy in phase III trials.
Kerbel RS; Grothey A
Nat Rev Clin Oncol; 2015 Jun; 12(6):313-4. PubMed ID: 25963090
[No Abstract] [Full Text] [Related]
36. Explaining the unexplainable: EGFR antibodies in colorectal cancer.
Grothey A; Lenz HJ
J Clin Oncol; 2012 May; 30(15):1735-7. PubMed ID: 22473160
[No Abstract] [Full Text] [Related]
37. When less is more: maintenance therapy in colorectal cancer.
Hubbard JM; Grothey A
Lancet; 2015 May; 385(9980):1808-10. PubMed ID: 25862518
[No Abstract] [Full Text] [Related]
38. S-1: another oral agent for patients with colorectal cancer.
Benson AB
Lancet Oncol; 2013 Dec; 14(13):1244-5. PubMed ID: 24225156
[No Abstract] [Full Text] [Related]
39. Can money really be no object when cancer care is the subject?
Saltz LB
J Clin Oncol; 2015 Apr; 33(10):1093-4. PubMed ID: 25691668
[No Abstract] [Full Text] [Related]
40. Translation from clinical trials to routine practice: how to demonstrate community benefit.
Roder D; Buckley E
Asia Pac J Clin Oncol; 2015 Mar; 11(1):1-3. PubMed ID: 25628060
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
